| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5870970 | Primary Care Diabetes | 2014 | 9 Pages |
Abstract
Type 2 diabetes (T2DM) diagnoses are skyrocketing, making treatment of this disease an increasing focus of primary care visits. Guidelines recommend insulin intensification over time to achieve HbA1c targets. We conducted a systematic review regarding patterns and trends of insulin intensification and barriers to intensification. Providers across primary and specialty care settings often did not intensify insulin regimens despite patients' clinical status. Even among progressed patients, HbA1c values remained high. The paucity of available studies prevented a comprehensive understanding of patterns and trends in insulin intensification. Such information is needed to assess the quality of pharmacologic care for patients with T2DM.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jennifer M. Polinski, John G. Connolly, Bradley H. Curtis, John D. Seeger, Kimela Gaskins, Magaly Perez, Benjamin F. Smith, William H. Shrank,